Notable
TAN for Substance Use Disorder
Primary and study completion pushed from Aug 31, 2026 to Aug 31, 2027
Spark Biomedical, Inc.Not applicable NCT07281261 Registry history of NCT07281261 on ClinicalTrials.gov (opens the registry)
Updated
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
Primary and study completion pushed from Aug 31, 2026 to Aug 31, 2027
Spark Biomedical, Inc.Not applicable NCT07281261 Registry history of NCT07281261 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Final enrollment: 23 participants (planned 30); Study completion date changed from estimate of Jul 20, 2026 to Sep 8, 2026
Spark Biomedical, Inc.Not applicable NCT07109349 Registry history of NCT07109349 on ClinicalTrials.gov (opens the registry)
Updated
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Not applicable | ||||
| NCT07281261 | tAN for Substance Use Disorder | Alcohol Use Disorder | Recruiting | 2026-09-28 |
| NCT07326722 | Delivering tAN to Reduce HMB: The LUNA Study | Heavy Menstrual Bleeding | Recruiting | 2026-09-28 |
| NCT05129020 | Neurostimulation to Improve NOWS Outcomes | Neonatal Opioid Withdrawal Syndrome | Active, Not Recruiting | 2026-06-02 |
| Not specified | ||||
| NCT06487533 | Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid… | Opioid Withdrawal | Recruiting | 2026-09-28 |